Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05654103 · ClinicalTrials.gov registry record · NA
Comparing Surgical and Endovascular Arteriovenous Fistula Creation
A NA study of End Stage Renal Disease on Dialysis, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 2
- Study locations
NCT05654103: Recruiting NA study of End Stage Renal Disease on Dialysis, sponsored by University of California, Los Angeles.
NCT05654103 is a NA study of End Stage Renal Disease on Dialysis that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 90 participants, above the 68-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (32% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05654103, a NA study of End Stage Renal Disease on Dialysis, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
Patients with end-stage kidney disease (ESKD) who use hemodialysis to filter their blood require vascular access for the dialysis machine; the most common type of vascular access is called an arteriovenous fistula (AVF). The AVF is a direct connect between an artery and vein. Until recently, AVFs were only created through surgery that requires general anesthesia and opening up the skin. Now there are 2 FDA-approved devices designed to create AVFs using endovascular techniques (endoAVF), which means a device that goes through the skin instead of opening the skin up. Also patients are not required to be under general anesthesia, they can receive local anesthesia instead. Due to the relatively new approval of these devices, there is not a randomized study to compare the results of endoAVF versus surgAVF. This study is a pilot study for an eventually larger scale study to compare the results of endoAVF versus surgAVF. The study aims to determine what the proportion of patients seeking hemodialysis access could qualify for receiving either an endoAVF , surgAVF, or both. Patients who are screened for hemodialysis access must undergo a duplex ultrasound of the blood vessels in the arm to confirm correct sizing. If participants qualify for both procedures they will be randomized to either endoAVF or surgAVF and will track the clinical and patient-reported outcomes of each procedure. Our pilot study hopes to enroll 90 participants. Those outcomes will inform a larger scale study. If the potential participant chooses to abstain from participation in the randomized trial, preferring to decide the method of AVF creation, we will offer to them a chance to join an endoAVF/surgAVF registry that will track the clinical outcomes of the procedure via medical record monitoring.
Primary Outcome
flow ≥ 500 ml/min and internal diameter \>0.5 cm
Conditions Studied
Interventions
- DEVICE endoAVF
- PROCEDURE surgAVF
Study Locations (2)
California
- UCLA Division of Vascular and Endovascular Surgery Clinic - Los Angeles
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-11-20 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What NCT05654103 shows while recruiting
NCT05654103 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, above the 68-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (32% higher).
The record links to 1 condition, with End Stage Renal Disease on Dialysis appearing as the primary indexed condition, and to 2 interventions - of which endoAVF is the first listed.
NCT05654103 reports a single indexed study location in California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05654103 about?
NCT05654103 is a clinical study titled "Comparing Surgical and Endovascular Arteriovenous Fistula Creation". Patients with end-stage kidney disease (ESKD) who use hemodialysis to filter their blood require vascular access for the dialysis machine; the most common type of vascular access is called an arteriovenous fistula (AVF). The AVF is a direct connect between an artery and vein. Until recently, AVFs w...
What is the current status of trial NCT05654103?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-11-20. Estimated completion is 2028-01-01.
What conditions does trial NCT05654103 study?
This clinical trial studies the following conditions: End Stage Renal Disease on Dialysis.
What interventions are being tested in trial NCT05654103?
The interventions under investigation include: endoAVF (DEVICE), surgAVF (PROCEDURE).
Who is sponsoring clinical trial NCT05654103?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05654103 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease on Dialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05654103's enrollment target sits among peer trials
90 3rd of 9 higher than 7 of 9 other End Stage Renal Disease on Dialysis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease on Dialysis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
RECRUITING · NA
-
The Home Blood Pressure (BP) Trial
ACTIVE NOT RECRUITING · NA
-
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
ACTIVE NOT RECRUITING · NA
-
Motivational Strategies To Empower African Americans To Improve Dialysis Adherence
COMPLETED · NA
-
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
COMPLETED · NA
-
The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI